ProCE Banner Activity

FcRn Pathway Inhibition in ITP

Slideset Download
Download this slideset on expert perspectives on FcRn pathway inhibition in patients with ITP.

Released: July 23, 2021

Expiration: July 22, 2022

Share

Faculty

David J. Kuter

David J. Kuter, MD, DPhil

Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Hematology Program Director
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

UCB Biopharma SRL

Faculty Disclosure

Primary Author

David J. Kuter, MD, DPhil

Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Hematology Program Director
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital
Boston, Massachusetts